Mercyhealth Adopts Omnicell's XR2 Automated Central Pharmacy System to Enhance Patient Safety

MOUNTAIN VIEW, Calif., March 27, 2018 /PRNewswire/ -- Omnicell, Inc. (NASDAQ: OMCL) today announced that Mercyhealth, a five-hospital and 85-facility system serving 15 counties in northern Illinois and southern Wisconsin, has chosen Omnicell's XR2 Automated Central Pharmacy System to help increase their pharmacy's efficiency, streamlining tasks while enhancing patient safety. The hospital plans to implement XR2, part of Omnicell's industry-leading medication management automation platform, in central pharmacy operations at its main campus in Rockford, IL.  

In considering new options for central pharmacy automation, Mercyhealth wanted a solution that would enhance operational efficiencies, allowing them to refocus staff to participate in clinical, patient-facing care initiatives. Positive interactions with hospital pharmacists can significantly impact patient satisfaction survey scores, according to the Hospital Consumer Assessment of Healthcare Providers and Systems.¹

Mercyhealth selected Omnicell's XR2 to replace their current pharmacy automation, building on initial technology investments. "Having the ability to streamline our pharmacists' efforts with the XR2 allows them to refocus their time to serving our patients," said Don Janczak, system director of pharmacy at Mercyhealth. "At Mercyhealth, hospital automation is something that we believe in, and our goal is to have a comprehensive inventory network that gives us more control with less labor. XR2's barcode utilization integrates into our nurses' scanning protocols, which helps reduce the risk of medication errors."

"Upgrading central pharmacy automation enables Mercyhealth to visualize their complete medication inventory across facilities to enhance medication delivery, reduce medication spend, and most importantly, free the pharmacy teams to increase their contribution to clinical care," said Nhat H. Ngo, executive vice president, Marketing, Strategy and Business Development at Omnicell.

About Mercyhealth

Mercyhealth (formerly Mercy Health System) was formed in January 2015 through the merger of Mercy Health System and Rockford Health System. Today, Mercyhealth is a vertically integrated, not-for-profit multi-regional health system comprising five hospitals, a wholly-owned insurance company, more than 700 employed physicians and over 85 primary and specialty care medical centers and clinics across more than 60 communities in 15 northern Illinois and southern Wisconsin counties. Mercyhealth provides over 75 specialty and sub-specialty services, including neonatal and pediatric intensive care, perinatal care, neurosurgery (brain and spine), heart and vascular care, cancer care, plastic and reconstructive surgery, da Vinci robotic surgery and much more.

About Omnicell

Since 1992, Omnicell (NASDAQ: OMCL) has been inspired to create safer and more efficient ways to manage medications and supplies across all care settings. Omnicell is revolutionizing the patient medication experience from hospital to home by empowering providers to keep each patient at the center of care. The Company's autonomous approach to medication management leverages a differentiated platform for hardware and workflow software solutions, real-time predictive intelligence, and performance-driven partnerships to help drive operational, financial, and clinical success for customers.

Supporting the highest level of patient safety is essential to excellent patient care. As a leader in medication and supply dispensing automation, central pharmacy automation, IV robotics, analytics software, and medication adherence and packaging systems, Omnicell is focused on delivering solutions for medication availability, affordability, safety, and adherence. Over 4,000 customers worldwide use Omnicell® automation and analytics solutions to increase operational efficiency, reduce medication errors, deliver actionable intelligence, and improve patient safety.

Omnicell's innovative medication adherence solutions, used by over 32,000 institutional and retail pharmacies in North America and the United Kingdom, are designed to improve patient engagement and adherence to prescriptions, helping to reduce costly hospital readmissions.

For more information about Omnicell, Inc. please visit www.omnicell.com.

OMCL-G

Footnotes:
¹ Erickson, A. K. (2013, October 11). "Survey says: Pharmacists affect patient satisfaction." Retrieved January 08, 2018 from https://www.pharmacist.com/survey-says-pharmacists-affect-patient-satisfaction

Editor's Notes:

1. All Omnicell news releases (financial, acquisitions, products, technology etc.) are issued exclusively by PR Newswire and are immediately thereafter posted on the company's external website, omnicell.com.
2. Omnicell and the Omnicell logo design are registered trademarks of Omnicell, Inc.
3. All other brand or product names may be trademarks or registered trademarks of their respective companies.

SOURCE Omnicell, Inc.

Related Links

http://www.omnicell.com